303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results

303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results

Bibliographic Details
Main Authors: Hassane Zarour, John Kirkwood, Joe-Marc Chauvin, Arivarasan Karunamurthy, Douglas Hartman, Richelle DeBlasio, Quanquan Ding, Ornella Pagliano, Amy Rose
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-23cceed6d50e4d5b9102fa53543f2387
record_format Article
spelling doaj-23cceed6d50e4d5b9102fa53543f23872020-12-11T10:04:43ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0303303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final resultsHassane Zarour0John Kirkwood1Joe-Marc Chauvin2Arivarasan Karunamurthy3Douglas Hartman4Richelle DeBlasio5Quanquan Ding6Ornella Pagliano7Amy Rose8Aff13 grid.21925.3d0000000419369000University of Pittsburgh Pittsburgh PA USA 16University of Pittsburgh Medical Center, Pittsburgh, PA, USAMedicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA2University of Pittsburgh, Pittsburgh, PA, USA2University of Pittsburgh, Pittsburgh, PA, USA1Hillman Cancer Center, Pittsburgh, PA, USA1Hillman Cancer Center, Pittsburgh, PA, USA1Hillman Cancer Center, Pittsburgh, PA, USA1Hillman Cancer Center, Pittsburgh, PA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Hassane Zarour
John Kirkwood
Joe-Marc Chauvin
Arivarasan Karunamurthy
Douglas Hartman
Richelle DeBlasio
Quanquan Ding
Ornella Pagliano
Amy Rose
spellingShingle Hassane Zarour
John Kirkwood
Joe-Marc Chauvin
Arivarasan Karunamurthy
Douglas Hartman
Richelle DeBlasio
Quanquan Ding
Ornella Pagliano
Amy Rose
303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
Journal for ImmunoTherapy of Cancer
author_facet Hassane Zarour
John Kirkwood
Joe-Marc Chauvin
Arivarasan Karunamurthy
Douglas Hartman
Richelle DeBlasio
Quanquan Ding
Ornella Pagliano
Amy Rose
author_sort Hassane Zarour
title 303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
title_short 303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
title_full 303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
title_fullStr 303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
title_full_unstemmed 303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
title_sort 303 phase ii trial of neoadjuvant nivolumab (nivo) and intra-tumoral (it) cmp-001 in high-risk resectable melanoma (neo-c-nivo): final results
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT hassanezarour 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT johnkirkwood 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT joemarcchauvin 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT arivarasankarunamurthy 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT douglashartman 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT richelledeblasio 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT quanquanding 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT ornellapagliano 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
AT amyrose 303phaseiitrialofneoadjuvantnivolumabnivoandintratumoralitcmp001inhighriskresectablemelanomaneocnivofinalresults
_version_ 1724386427306770432

Similar Items